{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:03:44Z","timestamp":1784732624291,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Nocturnal hypertension is an important phenotype of abnormal diurnal blood pressure (BP) variability and a known risk marker for target organ damage and cardiovascular events. This study aimed to assess the differential BP-lowering effects of esaxerenone vs. eplerenone on nocturnal BP in hypertensive patients with different nocturnal dipping patterns.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>This was a post hoc analysis of the \u201cEsaxerenone (CS-3150) Compared to Eplerenone in Patients with Essential Hypertension\u201d study (NCT02890173), which was a phase 3, multicenter, randomized, controlled, double-blind, parallel-group clinical study conducted in Japan. Ambulatory BP monitoring data were collected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Patients (n = 1,001) were randomized to esaxerenone 2.5 mg\/day (n = 331) or 5 mg\/day (n = 338), or eplerenone 50 mg\/day (n = 332). Reductions in nighttime systolic BP (95% confidence interval) were significantly greater with 2.5 and 5 mg\/day esaxerenone vs. eplerenone (\u22122.6 [\u22125.0, \u22120.2] and \u22126.4 mm Hg [\u22128.8, \u22124.0], respectively). Esaxerenone significantly reduced nighttime BP from baseline compared with eplerenone in non-dippers with previously uncontrolled BP. In addition, esaxerenone did not markedly alter nighttime BP in extreme dipper patients. In the esaxerenone 5 mg\/day group, esaxerenone-induced decreases in nighttime BP were greater than eplerenone-induced decreases in older patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Esaxerenone may be an effective treatment option for nocturnal hypertension, especially in older patients and those with a non-dipper pattern of nocturnal BP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpaa155","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T19:11:04Z","timestamp":1601665864000},"page":"540-551","source":"Crossref","is-referenced-by-count":34,"title":["Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A <i>Post Hoc<\/i> Analysis of the ESAX-HTN Study"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-4480","authenticated-orcid":false,"given":"Kazuomi","family":"Kario","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine , Shimotsuke, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University School of Medicine , Sendai, Miyagi, Japan"},{"name":"Katta General Hospital , Shiroishi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[{"name":"Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine , Suita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Okuda","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Co., Ltd. , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Co., Ltd. , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Co., Ltd. , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"2024020716044701400_CIT0001","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/HYPERTENSIONAHA.118.10971","article-title":"Nocturnal hypertension: new technology and evidence","volume":"71","author":"Kario","year":"2018","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0002","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.117.10238","article-title":"Consensus document on improving hypertension management in Asian patients, taking into account Asian characteristics","volume":"71","author":"Kario","year":"2018","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.107.087767","article-title":"Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0004","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/HYPERTENSIONAHA.111.00217","article-title":"Isolated nocturnal hypertension: a disease masked in the dark","volume":"61","author":"Li","year":"2013","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0005","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/HJH.0000000000001074","article-title":"Hypertension types defined by clinic and ambulatory blood pressure in 14\u200a143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study","volume":"34","author":"Omboni","year":"2016","journal-title":"J Hypertens"},{"key":"2024020716044701400_CIT0006","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jch.13652","article-title":"Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia network","volume":"21","author":"Kario","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2024020716044701400_CIT0007","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004872-200402000-00010","article-title":"Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure","volume":"22","author":"Cuspidi","year":"2004","journal-title":"J Hypertens"},{"key":"2024020716044701400_CIT0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.107.100610","article-title":"Brain microbleeds are associated with ambulatory blood pressure levels in a hypertensive population","volume":"51","author":"Henskens","year":"2008","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0009","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.HYP.27.1.130","article-title":"Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers","volume":"27","author":"Kario","year":"1996","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0010","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1001\/archinte.167.19.2116","article-title":"Blunted heart rate dip during sleep and all-cause mortality","volume":"167","author":"Ben-Dov","year":"2007","journal-title":"Arch Intern Med"},{"key":"2024020716044701400_CIT0011","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(07)61538-4","article-title":"Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study","volume":"370","author":"Boggia","year":"2007","journal-title":"Lancet"},{"key":"2024020716044701400_CIT0012","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/HJH.0b013e328322cd62","article-title":"Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients\u2014an Anglo-Scandinavian cardiac outcomes trial substudy","volume":"27","author":"Dolan","year":"2009","journal-title":"J Hypertens"},{"key":"2024020716044701400_CIT0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.109.133900","article-title":"Predictive role of the nighttime blood pressure","volume":"57","author":"Hansen","year":"2011","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0014","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1001\/jama.295.24.2859","article-title":"Diurnal blood pressure pattern and risk of congestive heart failure","volume":"295","author":"Ingelsson","year":"2006","journal-title":"JAMA"},{"key":"2024020716044701400_CIT0015","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/hy1001.092640","article-title":"Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives","volume":"38","author":"Kario","year":"2001","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0016","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00004872-200018070-00005","article-title":"Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study","volume":"18","author":"Ohkubo","year":"2000","journal-title":"J Hypertens"},{"key":"2024020716044701400_CIT0017","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/HYPERTENSIONAHA.114.03694","article-title":"Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: the Ambulatory Blood Pressure-International Study","volume":"64","author":"Palatini","year":"2014","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0018","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.118.12740","article-title":"Nighttime blood pressure measured by home blood pressure monitoring as an independent predictor of cardiovascular events in general practice","volume":"73","author":"Kario","year":"2019","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0019","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3109\/0886022X.2010.510615","article-title":"Nighttime hospital blood pressure\u2014a predictor of death, ESRD, and decline in GFR","volume":"32","author":"Drawz","year":"2010","journal-title":"Ren Fail"},{"key":"2024020716044701400_CIT0020","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024020716044701400_CIT0021","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2024020716044701400_CIT0022","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"2024020716044701400_CIT0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.119.13569","article-title":"Double-blind randomized phase 3 study comparing esaxerenone (CS-3150) and eplerenone in patients with essential hypertension (ESAX-HTN Study)","volume":"75","author":"Ito","year":"2020","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0024","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.0000056521.67546.AA","article-title":"Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study","volume":"107","author":"Kario","year":"2003","journal-title":"Circulation"},{"key":"2024020716044701400_CIT0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jch.13751","article-title":"2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network","volume":"22","author":"Kario","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2024020716044701400_CIT0026","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jash.2016.06.021","article-title":"Masked and nocturnal hypertension in the ARTS-DN ABPM sub-study with finerenone","volume":"10","author":"Ruilope","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"2024020716044701400_CIT0027","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pcad.2016.04.001","article-title":"Evidence and perspectives on the 24-hour management of hypertension: hemodynamic biomarker-initiated \u2018anticipation medicine\u2019 for zero cardiovascular event","volume":"59","author":"Kario","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"2024020716044701400_CIT0028","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1253\/circj.CJ-16-0740","article-title":"Riser pattern is a novel predictor of adverse events in heart failure patients with preserved ejection fraction","volume":"81","author":"Komori","year":"2017","journal-title":"Circ J"},{"key":"2024020716044701400_CIT0029","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00004872-200211000-00017","article-title":"Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study","volume":"20","author":"Ohkubo","year":"2002","journal-title":"J Hypertens"},{"key":"2024020716044701400_CIT0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0895-7061(96)00409-8","article-title":"Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure","volume":"10","author":"Kario","year":"1997","journal-title":"Am J Hypertens"},{"key":"2024020716044701400_CIT0031","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1470320310390404","article-title":"Efficacy of eplerenone added to renin-angiotensin blockade in elderly hypertensive patients: the Jichi-Eplerenone Treatment (JET) study","volume":"12","author":"Yano","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2024020716044701400_CIT0032","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.29.1.30","article-title":"Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The \u201cAd Hoc\u201d Working Group","volume":"29","author":"Staessen","year":"1997","journal-title":"Hypertension"},{"key":"2024020716044701400_CIT0033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0b013e3283599b6a","article-title":"Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension","volume":"31","author":"Colussi","year":"2013","journal-title":"J Hypertens"},{"key":"2024020716044701400_CIT0034","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijcard.2014.09.091","article-title":"Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: systematic review and meta-analysis","volume":"177","author":"Pelliccia","year":"2014","journal-title":"Int J Cardiol"},{"key":"2024020716044701400_CIT0035","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/01.CIR.100.15.1635","article-title":"Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension","volume":"100","author":"Uzu","year":"1999","journal-title":"Circulation"},{"key":"2024020716044701400_CIT0036","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/jch.12113","article-title":"Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients","volume":"15","author":"Kario","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2024020716044701400_CIT0037","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2015.06.015","article-title":"Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist","volume":"761","author":"Arai","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"2024020716044701400_CIT0038","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajh.2011.245","article-title":"Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension","volume":"25","author":"Shibata","year":"2012","journal-title":"Am J Hypertens"},{"key":"2024020716044701400_CIT0039","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11906-010-0112-8","article-title":"Obstructive sleep apnea and hypertension","volume":"12","author":"Calhoun","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"2024020716044701400_CIT0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ajh\/7.3.217","article-title":"Siesta and ambulatory blood pressure monitoring. Comparability of the afternoon nap and night sleep","volume":"7","author":"Bursztyn","year":"1994","journal-title":"Am J Hypertens"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaa155\/34175504\/hpaa155.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/34\/5\/540\/56612088\/hpaa155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/34\/5\/540\/56612088\/hpaa155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T17:47:20Z","timestamp":1707328040000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/34\/5\/540\/5961804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,11,9]]},"published-print":{"date-parts":[[2021,5,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaa155","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,11,9]]}}}